ask="0.3000"
ask_size="1400"
average_daily_volume="5818360"
bid="0.1750"
bid_size="25000"
book_value="0.1040"
change="+0.0034"
change_from_200_day_moving_average="-0.0656"
change_from_50_day_moving_average="-0.0055"
change_from_52_week_high="-0.4516"
change_From_52_week_low="0.0284"
change_in_percent="+1.8378%"
close="0.1884"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6780"
ebitda="-16.86M"
eps_estimate_current_year="-0.6200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="0.1700"
ex_dividend_date="N/A"
float_shares="125385000"
high="0.1900"
high_52_weeks="0.6400"
last_trade_date="2/10/2017"
last_trade_price="0.1884"
last_trade_size="4203"
last_trade_time="4:00pm"
low="0.1821"
low_52_weeks="0.1600"
market_capitalization="24.74M"
moving_average_200_day="0.2540"
moving_average_50_day="0.1939"
name="Immune Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="3.0000"
open="0.1900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-25.8142%"
percent_change_from_50_day_moving_average="-2.8561%"
percent_change_from_52_week_high="-70.5625%"
percent_change_from_52_week_low="+17.7500%"
previous_close="0.1850"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="1.1082"
price_per_book="1.7788"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="131291000"
short_ratio="1.5000"
stock_exchange="NCM"
symbol="IMNP"
volume="1619993"
weeks_range_52="0.1600 - 0.6400"
